Joshua N. Liberman, PhD

home / authors / joshua-n-liberman-phd

Articles

June 18th 2019

Assessing the Burden of Illness of Chronic Hepatitis C and the Impact of Direct-Acting Antiviral Use on Healthcare Costs in Medicaid

M. Christopher Roebuck, PhD Joshua N. Liberman, PhD

March 16th 2012

Reducing Long-Term Cost by Transforming Primary Care: Evidence From Geisinger's Medical Home Model

Daniel D. Maeng, PhD Jove Graham, PhD Thomas R. Graf, MD Joshua N. Liberman, PhD Nicholas B. Dermes, BS Janet Tomcavage, RN, MSN Duane E. Davis, MD Frederick J. Bloom Jr, MD, MMM Glenn D. Steele Jr, MD, PhD

ProvenHealth Navigator, Geisinger's version of advanced patient-centered medical homes, is associated with significant savings in total cost of care over time.

July 14th 2011

Adherence to Medication Under Mandatory and Voluntary Mail Benefit Designs

Joshua N. Liberman, PhD David S. Hutchins, MHSA, MBA Will H. Shrank, MD Julie Slezak, MS Troyen A. Brennan, JD, MD

Pharmacy benefit designs that mandate mail pharmacy use interfere with prescription drug access, particularly for individuals without previous mail pharmacy experience.

December 22nd 2010

Healthcare Information Technology Interventions to Improve Cardiovascular and Diabetes Medication Adherence

Alexander S. Misono, BA Sarah L. Cutrona, MD, MPH Niteesh K. Choudhry, MD, PhD Michael A. Fischer, MD, MS Margaret R. Stedman, PhD Joshua N. Liberman, PhD Troyen A. Brennan, MD, JD Sachin H. Jain, MD, MBA William H. Shrank, MD, MSHS

Despite increasing availability of healthcare information technology, a literature review showed few clinical data on medication adherence interventions using this technology.

December 16th 2010

Modes of Delivery for Interventions to Improve Cardiovascular Medication Adherence

Sarah L. Cutrona, MD, MPH Niteesh K. Choudhry, MD, PhD Michael A. Fischer, MD, MPH Amber Servi, BA Joshua N. Liberman, PhD Troyen A. Brennan, MD, JD William H. Shrank, MD, MSHS

In this review of randomized controlled trials designed to improve adherence to cardiovascular medications, electronic interventions and in-person, pharmacy-based interventions showed the highest success rates.